NANOG and ovarian carcinoma: Three mRNAs, CA11, LAMA4, MEDAG, were .01–.28-fold lower expressed and two mRNA, SPINT2 and NANOG, were 3.2–5.8-fold higher expressed in ovarian cancer ascites versus peritoneal fluid EVs.